Specific and nonspecific immune resistance enhancing activity of staphage lysate. 1981

H J Esber, and S J DeCourcy, and A E Bogden

The immunopotentiating activity of staphage lysate (SPL) was evaluated in terms of its immune protection against lethal bacterial infection and its antitumor activity. Mice were pretreated weekly with 10(8) viable, Staphylococcus aureus, strain 18Z for 3 weeks (Induction), followed by intraperitoneal SPL injections (Elicitation) at various times in relation to infectious challenge or tumor implantation. Induction without elicitation, or elicitation alone failed to provide protection against Klebsiella pneumoniae infection and resulted in only 30-40% survival against homologous infection with pathogenic S. aureus type III, whereas combined induction and elicitation produced enhanced resistance induction and elicitation regimens resulted in 50% and 80-100% survival in mice inoculated with K. pneumoniae and S. aureus, respectively. SPL had no antitumor effect in mice implanted with median survival time resulting from induction and elicitation in animals implanted which Ehrlich's ascites. This enhancement of immune resistance may possibly be related to activation of thymus-modulated lymphocytes and macrophages by SPL.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D005260 Female Females
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001430 Bacteriocins Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria. Bacteriocin,Lantibiotic,Lantibiotics
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

H J Esber, and S J DeCourcy, and A E Bogden
October 1985, Immunopharmacology,
H J Esber, and S J DeCourcy, and A E Bogden
May 1963, The Journal of the Medical Society of New Jersey,
H J Esber, and S J DeCourcy, and A E Bogden
October 1980, Irish medical journal,
H J Esber, and S J DeCourcy, and A E Bogden
January 1990, Acta microbiologica Hungarica,
H J Esber, and S J DeCourcy, and A E Bogden
January 1988, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
H J Esber, and S J DeCourcy, and A E Bogden
May 1981, Annals of plastic surgery,
H J Esber, and S J DeCourcy, and A E Bogden
January 1982, Journal of clinical microbiology,
H J Esber, and S J DeCourcy, and A E Bogden
January 1979, Annals of the New York Academy of Sciences,
H J Esber, and S J DeCourcy, and A E Bogden
May 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H J Esber, and S J DeCourcy, and A E Bogden
December 2007, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!